SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-042236
Filing Date
2024-04-05
Accepted
2024-04-05 16:00:29
Documents
7
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2024_def_proxy_stmt_no_x.htm DEF 14A 1274840
2 GRAPHIC img153403655_0.jpg GRAPHIC 13303
3 GRAPHIC img153403655_1.jpg GRAPHIC 120019
4 GRAPHIC img153403655_2.jpg GRAPHIC 125000
5 GRAPHIC img153403655_3.jpg GRAPHIC 13303
6 GRAPHIC img153403655_4.jpg GRAPHIC 1305542
7 GRAPHIC img153403655_5.jpg GRAPHIC 455053
  Complete submission text file 0000950170-24-042236.txt   4062056
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37378 | Film No.: 24826381
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)